Mangoceuticals Inc
MGRX
Company Profile
Business description
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Contact
17130 Dallas Parkway
Suite 240
DallasTX75248
USAT: +1 214 242-9619
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
We think Tesla stock is fairly valued.
stocks
The best global tech stocks to buy
These 12 undervalued technology stocks look attractive today.
stocks
Earnings margins to improve for mining specialist
Premium products drive margins yet shares fully valued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,102.90 | 15.70 | -0.17% |
| CAC 40 | 8,161.57 | 156.41 | -1.88% |
| DAX 40 | 25,617.14 | 390.49 | -1.50% |
| Dow JONES (US) | 52,786.07 | 628.18 | -1.18% |
| FTSE 100 | 10,700.64 | 111.02 | -1.03% |
| HKSE | 25,274.96 | 42.22 | -0.17% |
| NASDAQ | 26,421.41 | 85.58 | -0.32% |
| Nikkei 225 | 65,142.78 | 126.55 | -0.19% |
| NZX 50 Index | 13,819.43 | 26.53 | 0.19% |
| S&P 500 | 7,673.52 | 45.08 | -0.58% |
| S&P/ASX 200 | 8,911.40 | 16.20 | -0.18% |
| SSE Composite Index | 3,951.51 | 10.96 | 0.28% |